vs
Ernexa Therapeutics Inc.（ERNA）与Algorhythm Holdings, Inc.（RIME）财务数据对比。点击上方公司名可切换其他公司
Ernexa Therapeutics Inc.是一家总部位于美国的临床阶段生物技术企业，专注于开发针对存在高度未满足医疗需求的罕见神经内分泌、代谢类疾病的新型靶向疗法，致力于为缺乏有效治疗方案的患者群体提供新选择。
Algorhythm Holdings是一家专注于医疗领域人工智能临床决策支持解决方案的科技公司，主要服务北美地区医疗机构，旗下产品可提升诊疗质量、简化临床工作流程、降低运营成本。
ERNA vs RIME — 直观对比
营收规模更大
ERNA
是对方的-0.0倍
$-2.1M
损益表 — Q4 FY2024 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0K | $-2.1M |
| 净利润 | — | $-3.5M |
| 毛利率 | 100.0% | 117.3% |
| 营业利润率 | — | 135.4% |
| 净利率 | — | 169.1% |
| 营收同比 | — | 56.1% |
| 净利润同比 | 6.4% | 78.2% |
| 每股收益（稀释后） | — | $-0.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ERNARIME
| Q4 25 | — | $-2.1M | ||
| Q2 25 | — | $2.7M | ||
| Q4 24 | $1.0K | $-4.7M | ||
| Q3 24 | $487.0K | — | ||
| Q2 24 | $47.0K | $2.4M | ||
| Q1 24 | $47.0K | $2.4M | ||
| Q3 23 | $51.0K | $15.9M | ||
| Q2 23 | — | $2.6M |
净利润ERNARIME
| Q4 25 | — | $-3.5M | ||
| Q2 25 | — | $-809.0K | ||
| Q4 24 | — | $-16.0M | ||
| Q3 24 | $-26.6M | — | ||
| Q2 24 | $-5.5M | $-6.1M | ||
| Q1 24 | $-6.6M | $-2.4M | ||
| Q3 23 | $-5.6M | $97.5K | ||
| Q2 23 | — | $-2.5M |
毛利率ERNARIME
| Q4 25 | — | 117.3% | ||
| Q2 25 | — | 35.1% | ||
| Q4 24 | 100.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 13.3% | ||
| Q1 24 | — | 20.7% | ||
| Q3 23 | — | 23.4% | ||
| Q2 23 | — | 20.2% |
营业利润率ERNARIME
| Q4 25 | — | 135.4% | ||
| Q2 25 | — | -28.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | -463.9% | — | ||
| Q2 24 | -10491.5% | -252.2% | ||
| Q1 24 | -12312.8% | -94.3% | ||
| Q3 23 | -10794.1% | 0.7% | ||
| Q2 23 | — | -92.6% |
净利率ERNARIME
| Q4 25 | — | 169.1% | ||
| Q2 25 | — | -29.8% | ||
| Q4 24 | — | 340.0% | ||
| Q3 24 | -5462.8% | — | ||
| Q2 24 | -11763.8% | -250.8% | ||
| Q1 24 | -14142.6% | -97.6% | ||
| Q3 23 | -10962.7% | 0.6% | ||
| Q2 23 | — | -93.7% |
每股收益（稀释后）ERNARIME
| Q4 25 | — | $-0.36 | ||
| Q2 25 | — | $-0.24 | ||
| Q4 24 | — | $-89.56 | ||
| Q3 24 | $-73.70 | — | ||
| Q2 24 | $-15.34 | $-190.68 | ||
| Q1 24 | $-1.23 | $-73.76 | ||
| Q3 23 | $-1.03 | $0.03 | ||
| Q2 23 | — | $-0.64 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.7M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.7M | $-1.9M |
| 总资产 | $5.3M | $12.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ERNARIME
| Q4 25 | — | — | ||
| Q2 25 | — | — | ||
| Q4 24 | $1.7M | — | ||
| Q3 24 | $4.3M | — | ||
| Q2 24 | $2.6M | $1.2M | ||
| Q1 24 | $5.1M | $4.1M | ||
| Q3 23 | $4.6M | — | ||
| Q2 23 | — | $1.9M |
股东权益ERNARIME
| Q4 25 | — | $-1.9M | ||
| Q2 25 | — | $2.8M | ||
| Q4 24 | $1.7M | $-10.5M | ||
| Q3 24 | $-45.4M | — | ||
| Q2 24 | $-8.5M | $-872.0K | ||
| Q1 24 | $-3.4M | $5.2M | ||
| Q3 23 | $3.6M | $9.7M | ||
| Q2 23 | — | $9.5M |
总资产ERNARIME
| Q4 25 | — | $12.7M | ||
| Q2 25 | — | $12.7M | ||
| Q4 24 | $5.3M | $18.3M | ||
| Q3 24 | $7.7M | — | ||
| Q2 24 | $46.5M | $12.4M | ||
| Q1 24 | $49.7M | $19.9M | ||
| Q3 23 | $52.2M | $32.6M | ||
| Q2 23 | — | $15.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.8M | — |
| 自由现金流经营现金流 - 资本支出 | $-16.2M | — |
| 自由现金流率自由现金流/营收 | -1620500.0% | — |
| 资本支出强度资本支出/营收 | 36900.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-28.9M | — |
8季度趋势，按日历期对齐
经营现金流ERNARIME
| Q4 25 | — | — | ||
| Q2 25 | — | $-2.3M | ||
| Q4 24 | $-15.8M | $-1.5M | ||
| Q3 24 | $-6.3M | — | ||
| Q2 24 | $-2.3M | $-2.9M | ||
| Q1 24 | $-3.7M | $-2.6M | ||
| Q3 23 | $-5.8M | $1.4M | ||
| Q2 23 | — | $-2.5M |
自由现金流ERNARIME
| Q4 25 | — | — | ||
| Q2 25 | — | — | ||
| Q4 24 | $-16.2M | — | ||
| Q3 24 | $-6.3M | — | ||
| Q2 24 | $-2.5M | — | ||
| Q1 24 | $-3.8M | — | ||
| Q3 23 | — | $1.3M | ||
| Q2 23 | — | $-2.6M |
自由现金流率ERNARIME
| Q4 25 | — | — | ||
| Q2 25 | — | — | ||
| Q4 24 | -1620500.0% | — | ||
| Q3 24 | -1294.5% | — | ||
| Q2 24 | -5336.2% | — | ||
| Q1 24 | -8187.2% | — | ||
| Q3 23 | — | 8.5% | ||
| Q2 23 | — | -98.7% |
资本支出强度ERNARIME
| Q4 25 | — | — | ||
| Q2 25 | — | — | ||
| Q4 24 | 36900.0% | — | ||
| Q3 24 | 3.9% | — | ||
| Q2 24 | 529.8% | — | ||
| Q1 24 | 214.9% | — | ||
| Q3 23 | 0.0% | 0.2% | ||
| Q2 23 | — | 1.6% |
现金转化率ERNARIME
| Q4 25 | — | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | 14.09× | ||
| Q2 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
